Possible amelioration of oxidative stress damage via cyclo-oxygenase pathway by aqueous extract of Terminalia catappa leaves in alloxan induced diabetic rats

Ezekiel Etim  Ben; Asuquo Etim  Asuquo; Daniel Udofia  Owu

doi:10.30574/gscbps.2021.16.2.0215

Authors

Ezekiel Etim Ben Department of Physiology, Faculty of Basic Medical Sciences, University of Uyo, Akwa Ibom State Nigeria.
Asuquo Etim Asuquo Department of Physiology, Faculty of Basic Medical Sciences, University of Uyo, Akwa Ibom State Nigeria.
Daniel Udofia Owu Department of Physiology, Faculty of Basic Medical Sciences, University of Calabar, Cross River State Nigeria

DOI:

https://doi.org/10.30574/gscbps.2021.16.2.0215

Keywords:

Oxidative stress, Diabetes mellitus, Superoxide dismutase, Malondialdehyde, Aspirin, Meloxicam

Abstract

Cellular damage due to oxidative stress had been implicated in the pathogenesis of many diseases including diabetes mellitus. This study was to investigate possible amelioration of oxidative stress in diabetes mellitus by aqueous leaf extract of Terminalia catappa. Wistar rats weighing 200 -250g was divided into nine groups with 6 rats per group. The main test group has 5 groups while the group for assessing possible mechanism had 4 groups. Group 1 (control) and group 2(non-diabetic) received orally per kg body weight; 0.5ml distilled water and 130mg of Terminalia catappa respectively. Group 3 (diabetic), group 4 (diabetic + extract) and group 5 (diabetic + insulin) also respectively received 0.5ml distilled water, 130mg Terminalia. catappa extract and 0.75UI insulin subcutaneously. Groups 6, 7, 8 and 9 administered orally with aspirin; 30mg/kg, meloxicam; 2mg/kg and combination of extract with aspirin and meloxicam respectively. The experiment lasted for 14 days and glucose level ≥ 200mg/dl was considered diabetic following intraperitoneal injection of 150mg/kg body weight of alloxan. Results showed significant (p<0.05) increase in serum low density lipoprotein cholesterol (LDL-c), malondialdehyde (MDA) and a significant (p<0.05) decrease in superoxide dismutase (SOD) in diabetic group compared with control. The LDL and MDA were significantly (p<0.05) reduced while SOD increased significantly (p<0.05) when compared with diabetic group and the control following administration of Terminalia catappa, aspirin, meloxicam and insulin. The leaf extract of Terminalia catappa possess possible ameliorating potential on oxidative stress induced damages by impeding lipid peroxidation but improved on antioxidant enzyme in diabetic condition.

Metrics

Metrics Loading ...

References

Dos Santos J, Tewari S, Mendes R. The Role of Oxidative Stress in the Development of Diabetes Mellitus and Its Complications. Journal of Diabetes Research. 2019; 1-3.

Zhai R, Jian G, Chen T, Xie L, Xue R, Gao C, Wang N, Xu Y, Gui D. Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats. Journal of Diabetes Research. 2019; (1): 1-14.

PoljÅ¡ak B, Fink R. The protective role of antioxidants in the defence against ROS/RNS-mediated environmental pollution. Oxid Med Cell Longev. 2014; 671539.

Patricia PM. Reactive species and diabetes: counteracting oxidative stress to improve health. Curr. Opin. Pharmacol. 2009; 9: 771–779.

Wallace JI. Management of diabetes in elderly. Clin. Diabetes. 2004; 17: 1.

Mahboob M, Rahman MF, Groover P. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Singapore Med Journal. 2005; 46(7): 322.

Yuan Y, Jiao X, Lau WB, Wang Y, Christopher TA.Thioredoxin glycation: A novel posttranslational modification that inhibits its antioxidant and organ protective actions. Free Radic Biol Med. 2010; 49: 332-338.

Kang JH. Modification and inactivation of human Cu,Zn-superoxide dismutase by methylglyoxal. Mol Cells. 2003; 15: 194-199.

Szaleczky E, Prechl J, Fehér J, Somogyi A. Alterations in enzymatic antioxidant defence in diabetes mellitus--a rational approach. Postgrad Med J. 1999; 75: 13-17.

Moussa SA. Oxidative stress in diabetes mellitus. Romanian J Biophys. 2008; 18(3): 225-236.

Savita Khanna. Thiol Antioxidants, Ph.D. Dissertation. 2000; Department of Physiology University of Kuopio, Kuopio, Finland. 2000.

Deponte,M. Glutathione catalysis and the reaction mechanism of glutathione-dependent enzymes, Biochimica et BiophysicaActa. 2013; 18: 3217–3266.

Somogyi A, Rosta K, Pusztai P, Tulassay Z, Nagy G. Antioxidant measurements. Physiol Meas. 2007; 28(4): 41-55.

Lipinski B. Pathophysiology of oxidative stress in diabetes mellitus. J. Diabetes its Complications. 2001; 15(4): 203–210.

Pizzino G, Irrera N, Cucinotta M, Pallio G, Maninno F, Arcoraci V, Squadrito F, Altavilla D, Bitto A. Oxidative Stress: Harms and Benefits for Human Health. Oxid Med Cell Longev. 2017; 8416763.

Gutteridge, J. Lipid peroxidation and antioxidants as biomarkers of tissue damage. ClinChem. 1995; 41: 1819-1828.

Devasagayam TP, Boloor KK, Ramasarma T. Methods for estimating lipid peroxidation: an analysis of merits and demerits. Indian J BiochemBiophys. 2003; 40: 300-308.

Ayepola OR, Brooks NL, Oguntibeju, OO. Oxidative Stress and Diabetic Complications: The Role of Antioxidant Vitamins and Flavonoids. 2014.

Agrawal S, Banerjee S, Chatterjee, SN. Effects of oxygen on ferrous sulphate induced lipid peroxidation in liposomal membrane. Ind. J. Biochem. And Biophysics. 1985; 21: 331-334.

Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet. 1994; 344: 721–724.

Osawa T, Kavakishi S, Namiki M, Kuroda Y, Shankai OM, Waters MD. Antimutagenesis and Antimutagenesis mechanism, Edn 11, New York plenum. 1990; 139-153.

Houghton P. The role of plants in traditional medicine and current therapy. J Alter Comple Med. 1995; 1: 131-143.

Ben EE, Asuquo AE, Owu DU. Comparative Effect of Aspirin, Meloxicam and Terminalia catappa Leaf Extract on Serum Levels of some Inflammatory Markers in Alloxan Induced Diabetic Rat. AJRB. 2019a; 4(1): 1-10.

Ben EE, Asuquo, AE, Owu DU. (2019b) Serum Levels of Some Inflammatory Markers in Alloxan- Induced Diabetic Rats Treated with Aqueous Leaf Extract of Terminalia catappa and Exgenous Insulin. AJRIMPS. 2019b; 6(2): 1-9.

Lehmer J, Marwinski G, Lehr S, Jorhen P, Deecke I. Immunological and psychological benefits of Aromatherapy Massage, Eur J Immunol. 2005; 23(6): 179- 181.

Bernanke JM, Buttle DJ, Stapel CG, Lowe A, Duce IR. Developing novel anti-helminthic from plant cysteine proteins, parasites and vectors. Plant Med Sci. 2008; 86(7): 11-29.

Vijayaprakash S, Langeswaran K, Jagadeesan AJ, Revathy R, Balasubramanian MP. Protective efficacy of Terminalia catappa l. leaves against lead induced nephrotoxicity in experimental rats. Int J Pharm PharmSci. 2012; 4(3): 454-8.

Venkatalakshmi P, Brindha P, Induja K. In-vitro anti-oxidant and antitumor studies on Terminalia catappa bark. Int J Pharm PharmSci. 2013; 6(1): 1-3.

Katsumata K, Katsumata Y, Ozawa T, Katsumata J. Potentiating effect of combined usage of three sulfonylures drugs on the occurrence of alloxan diabetes in rats. Horm Metab Res. 1993; 25: 125-126.

Kulkarni S. Commonly used drugs, their doses and nature of action in laboratory animals. 3rd ed. VallabhPrakashan Delhi: Hand book of Experimental Pharmacology. 2005; 190-195.

Etuk E. Animals models for studying diabetes mellitus. Int J Agric Biol. 2010; 1: 130-4

Borgohain R, Lahon K, Das S. Gohain, K. Evaluation of mechanism of anti-diabetic activity of Terminalia chebulaon alloxan and Adrenaline induced Diabetic albino rats. Int J Pharm Investig. 2012; 3(3): 256-266.

Friedewald WT, Levy RI, Fredrickson DS. Estimationof the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972; 18: 499-502.

Singh G, Kumar A. A Study of Lipid Profile in Type 2 Diabetic Punjabi Population. Journal of Exercise Science and Physiotherapy. 2002; 8(1): 7-10.

Mona H, Sahar S, Hend S. Nanees A. Dyslipidemia in type 1 diabetes mellitus: Relation to diabetes duration, glycemic control, body habitus, dietary intake and other epidemiological risk factors. Egypt PediatrAssoc Gazette. 2015.

Shankarprasad D, Gundalli I, Mahantesh B, Kashinakunti S, Sunitha P. Lipid profile in Diabetes Mellitus. Indian Journal of Pathology and Oncology. 2015; 2(4): 290-294.

Glew RH. Lipid metabolism II: pathways of metabolism of special lipids. In: Devlin TM (ed) Textbook of biochemistry with clinical correlations, 6th edn. Wiley Liss, New Jersey. 2006; 695-741.

Haffner SM, for the American Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care. 2004; 27(1): 68–71

Alouffi S, Faisal M, Alatar AA, Ahmad S. Oxidative modification of LDL by various physiochemical techniques: Its probable role in diabetes coupled withCVDs. BioMedResearch International. 2018; 1-7.

Seok Man S. Reactive Oxygen andNitrogen Species in Pathogenesis of Vascular Complications of Diabetes. Diabetes Metab J. 2002; 36: 190-198.

Walzem RL, Watkins S, Frankel, EN, Hansen RJ, German JB. Older plasma lipoproteins are more susceptible to oxidation: A linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease. PNAS. 1995; 92(16): 7460–7464.

Virella G, Lopes-Virella M. Lipoprotein autoantibodies: measurement and significance. Clinical and Diagnostic Laboratory Immunology. 2003; 10(4): 499–505.

Bobryshev YV. Monocyte recruitment and foam cell formation in atherosclerosis. Micron. 2006; 37: 208–22.

Bray TM. Dietary Antioxidants and Assessment of Oxidative Stress. Nutr. 200; 16: 578-80.

Ayala A, Muñoz M, Argüelles S. Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal. Oxidative Medicine and Cellular Longevity. 2014; 6: 360438.

Yin H, Xu L, Porter NA. Free radical lipid peroxidation: mechanisms and analysis, Chemical Reviews. 2011; 111(10): 5944–5972.

Hua J, Malinski T. Variable Effects of LDL Subclasses of Cholesterol on Endothelial Nitric Oxide/Peroxynitrite Balance – The Risks and Clinical Implications for Cardiovascular Disease. Int J Nanomedicine. 2019; 14: 8973-8987.

Singh Z, Karthigesu I, Singh P, Kaur R. Use of Malondialdehyde as a Biomarker for Assessing Oxidative Stress in Different Disease Pathologies: a Review (OPEN ACCESS). Iranian J Public Health. 2014; 43: 7-16.

Losada M, Alio J. Malondialdehyde serum concentration in type-1 diabetic with and without retinopathy. Doc Ophthalmol. 1996; 93: 223-9.

Vessby J, Basu S, Mohsen R, Berne C, Vessby B. Oxidative stress and antioxidant status in type 1 diabetes mellitus. Journal of Internal Medicine. 2002; 251: 69-76.

Ozdemir G, Ozden M, Maral H, Kuskay S, Cetinalp P, Tarkun I. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria. Ann ClinBiochem. 2005; 42: 99−104.

Singhania N, Puri D, Madhu S, Sharma S. Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy, QJM: An International Journal of Medicine. 2008; 101(6): 449–455.

Mahreen R, Mohsin M, Nasreen Z, Siraj M, Ishaq M. significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction. Int J Diabetes Dev Ctries. 2010; 30: 49−51.

Salem M, Kholoussi S, Κholoussi N, Fawzy R. Malondialdehyde and trace element levels in patients with type 2 diabetes mellitus. Archives of Hellenic Medicine. 2011; 28(1):83-88.

Slatter D, Bolton C, Bailey, A. The importance of lipid-derived malondialdehyde in diabetes mellitus Diabetologia. 2000; 43: 550-557.

Zhang Y, Chen SY, Hsu T, Santella RM. Immunohistochemical detection ofmalondialdehyde-DNA adducts in humanoral mucosa cells. Carcinogenesis. 2002; 23: 207-211.

Chuan J, Rouzer C, Marnett L, Pietenpol J. Induction of cell cycle arrest by the endogenous product of lipid peroxidation, malondialdehye. Carcinogenesis. 1998; 19: 1275-1283.

Humaira M, Raqeeb, Memon A, Khoharo H. Malondialdehyde, Blood Lipids and Antioxidant Activity in Newly Diagnosed Type 2 Diabetics. J LiaquatUni Med Health Sci. 2016; 15(2): 78-82.

Prechl J, Fehér J, Somogyi A. Alterations in enzymatic antioxidant defence in diabetes mellitus − a rational approach Erika Szaleczky. Postgrad Med J. 1999; 75: 13–17.

Djordjević G, Djurić S, Djordjević V, Apostolski S, Živković, M. The role of oxidative stress in pathogenesis of diabetic neuropathy: erythrocyte superoxide dismutase, catalase and glutathione peroxidase level in relation to peripheral nerve conduction in diabetic neuropathy patients. In: C. Croniger (Ed.), Role of the Adipocyte in Development of Type 2 Diabetes. 2011; 153-172. Rijeka, Croatia: InTech

Brown H, Briggs O. (Clinical Relevance of Superoxide Dismutase and Glutathione Peroxidase Levels in Management of Diabetes Type2. IJCMR. 2016; 3(5): 1380-1382.

Madi M, Babu S, Kumari S, Shetty S, Achalli S, Madiyal A, Bhat M.. Status of Serum and Salivary Levels of Superoxide Dismutase in Type 2 Diabetes Mellitus with Oral Manifestations: A Case Control Study. Ethiopian journal of health sciences. 2016; 26(6): 523–532.

Bolajoko E, Mossanda K, Adeniyi F, Akinosun O, Fasanmade A, Moropane M. Antioxidant and oxidative stress status in type 2 diabetes and diabetic foot ulcer, South African Medical Journal. 2008; 98(8): 614–617.

Fujita H, Fujishima S, Chida, F. Reduction of renal superoxide dismutase in progressive diabetic nephropathy, Journal of the American Society of Nephrology. 2009; 20(6): 1303–1313.

Feng G, Gao J, Zhang P. Decreased serum extracellular superoxide dismutase activity is associated with albuminuria in Chinese patients with type 2 diabetes mellitus, ActaDiabetologica. 2017; 54(11): 1047–1055.

Fukai T, Folz R, Landmesser U, Harrison D. Extracellular superoxide dismutase and cardiovascular disease. Cardiovascular Research. 2002; 55(2): 239–249.

Younus H. Therapeutic potentials of superoxide dismutase. Int J Health Sci (Qassim). 2018; 12(3): 88-93.

Shukla K, Dikshit P, Tyagi MK, Shukla R, Gambhir JK. Ameliorative effect of Withania coagulans on dyslipidemia and oxidative stress in nicotinamide streptozotocin induced diabetes mellitus. Food and Chemical Toxicology. 2012; 50(10): 3595–3599.

Lucchesi AN, Freitas NT, Cassettari LL, Marques SF, Spadella CT. Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: a mechanism for diabetic chronic liver disease. Acta Cirurgica Brasileira. 2013; 28(7): 502–508.

Adachi T, Ohta H, Hirano K, Hayashi K, Marklund SL. Non-enzymatic glycation of human superoxide dismutase. Biochem J. 1991; 279: 263–7.

Szaleczky E, Prechl J, Fehér J, Somogyi A. Alterations in enzymatic antioxidant defence in diabetes mellitus − a rational approach. Postgrad Med J. 1999; 75: 13–17.

Nawale R, Mourya VK, Bhise S. Non-enzymatic glycation of proteins: A cause for complications in diabetes. Indian journal of biochemistry & biophysics. 2007; 43: 337-44.

Negre-Salvayre A, Salvayre R, Augé N, Pamplona R, Portero-Otín M. Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal. 2009; 11: 3071–3109.

Nagai R, Shirakawa J, Fujiwara Y, Ohno R, Moroishi N, Sakata N, Nagai M. Detection of AGEs as markers for carbohydrate metabolism and protein metabolism. J. Clin. Biochem. Nutr. 2014; 55: 1–6.

Sadowska-Bartosz I, Bartosz G. Prevention of protein glycation by natural compounds. Molecules. 2015; 20(2): 3309-3334.

Vergès, B Lipid Disorders in Type 1 Diabetes, Type 1 Diabetes - Complications, Pathogenesis, and Alternative Treatments. 2011. Chih-Pin Liu, IntechOpen.

Mishra A, Sharma AK, Kumar S, Saxena AK, Pandey A. Bauhinia variegata leaf extracts exhibit considerable antibacterial, antioxidant, and anticancer activities. BioMed Research International. Hindawi Publishing Corporation. 2013; 10.

Ram A, Laura P, Gupta R, Kumar P, Sharma VN. Hypocholesterolaemic effects of Terminalia arguna tree bark. J. Ethanopharmacol. 1997; 55(3): 165-169.

Adeneye AA, Adeneke TI, Adeneye AK. Hypoglycemic and hypolipidemic effects of the aqueous leaves extracts of Clerodendrumcapitatum in wistar rats. J. Ethanopharmacol. 2001; 116(1): 7-10.

Wardlaw GM, Kessel MW. Perspective in nutrition, 5th edn. McGraw-Hill, Boston. 2002.

Lin C, HsuY, Lin T. Antioxidant and free radical scavenging effects of the tannins of Terminalia catappa L. Anticancer Res. 2001; 21: 237–43.

Annegowda HV, Anwar LN, Mordi MN, Ramanathan S, Mansor SM. Influence of sonication on the phenolic content and antioxidant activity of Terminalia catappa L. leaves. Pharmacognosy Res. 2010; 2: 368–73.

Yoon JH, Baek SJ. Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med J. 2005; 46(5): 585-96.

Desai SJ, Prickril B, Rasooly A. Mechanisms of Phytonutrient Modulation of Cyclooxygenase-2 (COX-2) and Inflammation Related to Cancer. Nutr Cancer. 2018; 70(3): 350-375.

Wang HR, Sui HC, Zhu BT. Ellagic acid, a plant phenolic compound, activates cyclooxygenase mediated prostaglandin production. Exp Ther Med. 2019; 18(2): 987-996.